Indian Stock Market: Top Picks and Sector Outlook
A host of global and domestic brokerages have released fresh views on several Indian companies, including ICICI Lombard, Info Edge, Tata Steel, and more, ahead of the upcoming trading session.
Pharmaceuticals Sector Outlook
Morgan Stanley has flagged mixed regulatory risk profiles across Cipla, Dr Reddy’s Laboratories, and Sun Pharma. Cipla’s lanreotide is seen as the most at-risk product, while Sun Pharma faces compliance risks at its generic injectable facility. However, Sun Pharma’s focus on specialty products limits the earnings risk.
IT Services Sector Outlook
Citi maintains a Sell rating with a target price of Rs 1,300 for Info Edge. The Q3 business update showed steady billings growth, but non-recruitment verticals remain more competitive than recruitment. Growth and profitability in non-recruitment businesses are improving gradually, but GenAI-related disruption poses a medium-term headwind to the core business.
Banking Sector Outlook
Citi maintains a Buy rating with a target price of Rs 1,175 for HDFC Bank and Rs 1,750 for ICICI Bank. The growth outlook is improving, though risks of further rate cuts persist. Earnings are expected to remain healthy for both banks, driven by stronger growth and broadly stable NIMs.
Telecom Sector Outlook
Citi maintains a Buy rating with a target price of Rs 2,760 for Bharti Airtel and Rs 510 for Indus Towers. 2026 is seen as a year of growth and re-rating for the sector, driven by potential tariff hikes and AGR relief.
Consumer Staples Sector Outlook
Citi expects sequential improvement in consumer staples growth in Q3, supported by lower pricing across categories. Top picks in the sector include Britannia, Godrej Consumer, and Varun Beverages.